Jim Natal was diagnosed with type 1 diabetes at 30 years old in 1978. 38 years later, he still struggles with maintaining the balance between controlling his diabetes and leading a fulfilling life without worrying about every high or low blood sugar. In his first book of poetry, In the Bee Trees, he shares the story of his diagnosis:
Learning To Live With It
Barbara taught me to give injections
to an orange, thick pop of penetration
through the skin, short smooth glide
into soft tissue under. Slowly, with control,
push down on the plunger, and quick
backward dart toss, remove the syringe.
I practiced in her office, still dazed from
diagnosis, seeing through pinpoint pupils,
eyes after a strobe flash. Stretched like surgical
tubing colorless with tension, I was renamed
after a disease, time now measured in gleaming
needle pricks, insulin units, blood sugar levels.
My wife sobbed in the car parked beneath
the medical building, rusty pipes wrapped and
painted white, strung along the oppressive ceiling.
She cried because we didn’t have much money.
For the money, not for me. In that time of change
there were changes yet to come.
Barbara said I would learn to manage it by myself.
She said I had no choice.
A short update on Maine bill LD 673, An Act to Create the Insulin Safety Net Program.
Follow us on Facebook, Instagram, and Twitter @betacellpodcast. …
100 years after the discovery of insulin, stories of people falling through the gaps in American healthcare.
Follow us on Facebook, Instagram, and …
Craig and Hannah discuss how Beyond Type 1 accepting money from insulin makers caused him to resign from their Leadership Council.
Follow us on …
When Hannah tweeted at Montana House Rep. Jessica Karjala (D) about how her insulin co-pay cap bill wouldn’t actually help that many people with …
We talked to Ashley Butler, Ph.D. about her co-authored paper Type 1 Diabetes Self‐Management Behaviors among Emerging Adults: Racial/Ethnic …
Super Bowl Sunday, the biggest day of the year for football, chicken wings, day drinking, and Dexcom? We break down the pros and cons (but mostly cons) of Dexcom’s first ever Super Bowl ad …